Pressure BioSciences, Inc. Reports Q4 and FY 2022 Financial Results, ...
Pressure BioSciences, Inc. Reports Q4 and FY 2022 Financial Results, ...
Stay updated with breaking news from Technical Highlights. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pressure BioSciences, Inc. Reports Q4 and FY 2022 Financial Results, ...
$75,000 Pilot Lot Payment Received for Phase I of Safer Medical of Montana Agreement; Phases II/III Commercial Scale-Up. 1st Half 2023 Revenues Over $1 Million
Resources Continue to Pivot to UST Platform Commercialization, Achieving Major Progress and Traction; Revolutionary Nanoemulsions Technology Expected to Drive Major Growth to Profitability in 2023Investor
22.11.2022 - Resources Continue to Pivot to UST Platform Commercialization, Achieving Major Progress and Traction; Revolutionary Nanoemulsions Technology Expected to Drive Major Growth to Profitability in 2023Investor Call Scheduled for Tuesday, November 22, ...
Q4 and FY2021 Total Revenue Increased 91% and 64% Respectfully Over Same Periods in 2020;PCT, BaroFold, and PBI Agrochem Groups Scored Important Gains in 2021;UST Platform Achieved Critical 2021 Goals